Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bliv vs LillyDirect Foundayo

Bliv
Graded #165

Higher grade

vs+0.3999999999999915
LillyDirect Foundayo
Graded #174

Lower grade

The verdict

Bliv takes it — 67.6/100 to 67.2/100, but only just.

Bliv grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider focused on personalized GLP-1 weight loss programs. LillyDirect Foundayo is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBliv +4
76
72
Dose & formulationBliv +5
64
59
Clinical oversightBliv +4
82
78
Labs & monitoringBliv +1
53
52
FulfillmentLillyDirect Foundayo +15
65
80
Contract termsLillyDirect Foundayo +10
45
55
Bliv · left barLillyDirect Foundayo · right bar

The numbers

MetricBlivLillyDirect Foundayo
WeighScore67.6/10067.2/100
GradeCC
Scorecard rank#165#174
Semaglutide$58/mo (starting dose, compounded)Not disclosed
Tirzepatide$99/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Bliv

Graded #165 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
LillyDirect Foundayo

Graded #174 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard